当前位置: 首页 > 期刊 > 《新医学》 > 20183
编号:13596826
传统改善病情的抗风湿药对骨代谢的影响(4)
http://www.100md.com 2018年3月1日 《新医学》 20183
     [13]Rexhepi S, Rexhepi M, Sahatiu-Meka V, Mahmutaj V, Boshnjaku S. The impact of low-dose disease-modifying anti-rheumatics drugs (DMARDs) on bone mineral density of premenopausal women in early rheumatoid arthritis. Med Arch,2016,70(2):101-103.

    [14]Swierkot J, Gruszecka K, Matuszewska A, Wiland P. Assessment of the effect of methotrexate therapy on bone metabolism in patients with rheumatoid arthritis. Arch Immunol Ther Exp (Warsz),2015,63(5):397-404.

    [15]莫淡雅,刘春芳,林娜.雷公藤甲素对胶原诱导型关节炎小鼠骨与关节的影响.中国中医药信息杂志,2009,16(11):33-36.

    [16]Li H, Zhang YY, Tan HW, Jia YF, Li D. Therapeutic effect of tripterine on adjuvant arthritis in rats.J Ethnopharmacol, 2008,118(3):479-484.

    [17]Venkatesha SH, Astry B, Nanjundaiah SM, Yu H, Moudgil KD. Suppression of autoimmune arthritis by Celastrus-derived Celastrol through modulation of pro-inflammatory chemokines. Bioorg Med Chem,2012,20(17):5229-5234.

    [18]彭柳瑩,钱晨,谈文峰,冯小可,张前德.雷公藤红素对破骨细胞及胶原诱导关节炎小鼠中趋化因子CXCL2表达的影响.云南中医学院学报,2014,37(2):1-5.

    [19]Xu HH,Zhao HY,Lu C, Qiu A, Wang G,Huang J,Guo MH,Guo BS,Tan Y,Cheng X. Triptolide inhibits osteoclast differentiation and bone resorption in vitro via enhancing the production of IL-10 and TGF-β1 by regulatory T cells. Mediators Inflamm,2016,2016: 8048170.

    [20]Jin C, Zhang P, Zhang M, Zhang X, Lv L, Liu H, Liu Y, Zhou Y. Inhibition of SLC7A11 by sulfasalazine enhances osteogenic differentiation of mesenchymal stem cells by modulating BMP2/4 expression and suppresses bone loss in ovariectomized mice. J Bone Miner Res,2017,32(3):508-521.

    [21]Kaya G, Koak E, Akbal E, Ta A, Kklü S. Comparison of the possible risk factors of bone mineral density in subjects with ulcerative colitis and healthy subjects.South Med J,2011,104(11):747-751., 百拇医药(黄正平 丰帆 李天旺)
上一页1 2 3 4